Ashley Di Meo

923 total citations
24 papers, 661 citations indexed

About

Ashley Di Meo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ashley Di Meo has authored 24 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Ashley Di Meo's work include Renal cell carcinoma treatment (7 papers), Advanced Proteomics Techniques and Applications (5 papers) and Renal and related cancers (5 papers). Ashley Di Meo is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Advanced Proteomics Techniques and Applications (5 papers) and Renal and related cancers (5 papers). Ashley Di Meo collaborates with scholars based in Canada, United States and China. Ashley Di Meo's co-authors include George M. Yousef, Maria Pasic, Yufeng Cheng, Eleftherios P. Diamandis, Michael A.S. Jewett, Ihor Batruch, Antonio Finelli, Aaron D. Schimmer, Jonathan Boss and Marshall Brown and has published in prestigious journals such as Blood, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Ashley Di Meo

21 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Di Meo Canada	12	350	248	156	126	71	24	661
Jianhuang Li China	14	422 1.2×	219 0.9×	82 0.5×	166 1.3×	31 0.4×	24	640
Jae‐Young Kim South Korea	12	320 0.9×	157 0.6×	119 0.8×	123 1.0×	24 0.3×	22	605
Charles Ming Lok Chan China	15	283 0.8×	171 0.7×	108 0.7×	252 2.0×	47 0.7×	20	598
Karol Jelonek Poland	16	542 1.5×	289 1.2×	111 0.7×	103 0.8×	69 1.0×	32	743
M. Amneus United States	10	354 1.0×	245 1.0×	67 0.4×	139 1.1×	169 2.4×	18	854
Songbai Wang China	14	164 0.5×	126 0.5×	137 0.9×	169 1.3×	40 0.6×	41	708
Chiao‐Yun Lin Taiwan	18	410 1.2×	146 0.6×	92 0.6×	151 1.2×	30 0.4×	71	822
Marilyn Intengan United States	9	401 1.1×	105 0.4×	63 0.4×	173 1.4×	55 0.8×	12	679
Adriana L. Gonzalez United States	17	722 2.1×	221 0.9×	284 1.8×	349 2.8×	136 1.9×	25	1.1k
Anthea J. Stanley United Kingdom	15	536 1.5×	225 0.9×	237 1.5×	110 0.9×	275 3.9×	21	851

Countries citing papers authored by Ashley Di Meo

Since Specialization

Citations

This map shows the geographic impact of Ashley Di Meo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Di Meo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Di Meo more than expected).

Fields of papers citing papers by Ashley Di Meo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Di Meo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Di Meo. The network helps show where Ashley Di Meo may publish in the future.

Co-authorship network of co-authors of Ashley Di Meo

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Di Meo. A scholar is included among the top collaborators of Ashley Di Meo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Di Meo. Ashley Di Meo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agmon, Inbar Nardi, et al.. (2025). Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study. Cardio-Oncology. 11(1). 18–18.

Bohn, Mary Kathryn, et al.. (2025). Evaluation of pre-analytical factors impacting urine test strip and chemistry results. Clinical Chemistry and Laboratory Medicine (CCLM). 63(6). 1169–1178.

Willsmore, Zena, Lucy H. Booth, Akshay J. Patel, et al.. (2025). Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma. Journal for ImmunoTherapy of Cancer. 13(5). e011682–e011682. 2 indexed citations

Selvaratnam, Rajeevan, et al.. (2024). The stability of 65 biochemistry analytes in plasma, serum, and whole blood. Clinical Chemistry and Laboratory Medicine (CCLM). 62(8). 1557–1569. 9 indexed citations

Meo, Ashley Di, et al.. (2024). Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System. The Journal of Applied Laboratory Medicine. 9(3). 579–585. 2 indexed citations

Brinc, Davor, et al.. (2024). Macrotroponin interference in patients receiving cardiotoxic breast cancer therapy: A pilot study. Clinica Chimica Acta. 558. 119020–119020.

Meo, Ashley Di, Liyan Ma, Kevin Yau, et al.. (2023). Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patients. Clinical Biochemistry. 121-122. 110681–110681. 1 indexed citations

Meo, Ashley Di, Mehrdad Yazdanpanah, Victoria Higgins, et al.. (2023). Highly sensitive tandem mass spectrometric measurement of serum estradiol without derivatization and pediatric reference intervals in children and adolescents. Clinical Chemistry and Laboratory Medicine (CCLM). 61(10). 1820–1828. 3 indexed citations

Ding, Qiang, Zsuzsanna Lichner, Sung Sun Kim, et al.. (2022). The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance. Journal of Clinical Medicine. 11(2). 369–369. 1 indexed citations

10.

Aghel, Nazanin, Dakota Gustafson, Ashley Di Meo, et al.. (2021). Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment. JCO Precision Oncology. 5(5). 485–491. 12 indexed citations

11.

Meo, Ashley Di, Jessica Miller, Davor Brinc, et al.. (2021). Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response. The Journal of Applied Laboratory Medicine. 7(1). 57–65. 15 indexed citations

12.

Meo, Ashley Di, et al.. (2020). Proteomic Profiling of the Human Tissue and Biological Fluid Proteome. Journal of Proteome Research. 20(1). 444–452. 11 indexed citations

13.

Meo, Ashley Di, Marshall Brown, Antonio Finelli, et al.. (2019). Prognostic urinary miRNAs for the assessment of small renal masses. Clinical Biochemistry. 75. 15–22. 23 indexed citations

14.

Meo, Ashley Di, Ihor Batruch, Marshall Brown, et al.. (2019). Searching for prognostic biomarkers for small renal masses in the urinary proteome. International Journal of Cancer. 146(8). 2315–2325. 29 indexed citations

15.

Meo, Ashley Di, Ihor Batruch, Marshall Brown, et al.. (2019). Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass. American Journal Of Pathology. 189(12). 2366–2376. 12 indexed citations

16.

Meo, Ashley Di, et al.. (2017). Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Molecular Cancer. 16(1). 80–80. 265 indexed citations

17.

Meo, Ashley Di, et al.. (2016). An integrated proteomic and peptidomic assessment of the normal human urinome. Clinical Chemistry and Laboratory Medicine (CCLM). 55(2). 237–247. 27 indexed citations

18.

Meo, Ashley Di, Andreas Scorilas, Fabio Rotondo, et al.. (2015). Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. Clinical & Experimental Metastasis. 32(6). 531–541. 20 indexed citations

19.

Meo, Ashley Di, Fabio Rotondo, Kálmán Kovács, et al.. (2014). Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas. Applied immunohistochemistry & molecular morphology. 23(6). 433–437. 4 indexed citations

20.

Meo, Ashley Di, Eleftherios P. Diamandis, Henry Rodriguez, et al.. (2014). What Is Wrong with Clinical Proteomics?. Clinical Chemistry. 60(10). 1258–1266. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact